Correlation of NPM1 Type A Mutation Burden With Clinical Status and Outcomes in Acute Myeloid Leukemia Patients With Mutated NPM1 Type A

BACKGROUND: Nucleophosmin gene (NPM1) mutation may be a good molecular marker for assessing the clinical status and predicting the outcomes in AML patients. We evaluated the applicability of NPM1 type A mutation (NPM1-mutA) quantitation for this purpose. METHODS: Twenty-seven AML patients with norma...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Su Yeon, Park, Sang Hyuk, Kim, In-Suk, Yi, Jongyoun, Kim, Hyung-Hoi, Chang, Chulhun L., Lee, Eun Yup, Cho, Young-Uk, Jang, Seongsoo, Park, Chan-Jeoung, Chi, Hyun-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940481/
https://www.ncbi.nlm.nih.gov/pubmed/27374703
http://dx.doi.org/10.3343/alm.2016.36.5.399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940481/
https://www.ncbi.nlm.nih.gov/pubmed/27374703
http://dx.doi.org/10.3343/alm.2016.36.5.399

Ejemplares similares